study question: How is vascular endothelial growth factor (VEGF) expression regulated by hypoxia inducible factor 1 alpha (HIF1A) during menstruation? summary answer: After progesterone (P4) withdrawal, HIF1A was activated and it directly up-regulated VEGF mRNA expression and this regulation was the highest during endometrium breakdown in the mouse menstrual-like model. what is known already: VEGF, an important angiogenic factor, is known to be essential for endometrial repair, particularly in angiogenesis and re-epithelialization. However, its upstream regulation has not been fully clarified. HIF1 is the first transcription factor response to hypoxia and is closely associated with angiogenesis; it is also an upstream regulator of VEGF mRNA. study design, size, duration: We investigated the changes in the expression of HIF1A and VEGF after P4 withdrawal and after HIF1A inhibition. The total number of mice used was 62. The treatment duration in the mouse menstrual-like model was 8 days.
Introduction
Menstruation is one of the most puzzling physiological phenomena in primates, elephant shrews and some bat species. During each menstrual cycle, the endometrium undergoes proliferation, decidualization, menstruation and post-menstrual repair in sequence, which is under the delicate control of steroidal hormones. Progesterone (P4) withdrawal is the known initiator of menstruation (Girling and Rogers, 2009 ). During the post-menstrual phase, angiogenesis is an important process for endometrial repair and regeneration (Maybin and Critchley, 2009) and involves vascular endothelial growth factor (VEGF), one of the key factors of angiogenic stimulation (Chennazhi and Nayak, 2009; Girling and Rogers, 2009; Sakurai and Kudo, 2011) . In the human menstrual cycle, VEGF mRNA and protein are present during all phases in the endometrium; however, its expression increases during the late secretory phase and menses (Maybin et al., 2011a,b,c) . Recently, VEGF blockade was reported to completely inhibit neovascularization and delay endometrial repair in both mouse and rhesus menstrual-like models, which confirms that VEGF is essential for endometrial repair (Fan et al., 2008) , and also emphasizes its role in menstruation.
Hypoxia inducible factor 1 (HIF1) is the first transcription factor response to hypoxia, and is closely associated with angiogenesis (Semenza, 2010) . HIF1 is a heterodimeric transcription factor that contains two subunits: hypoxia-induced HIF1 alpha (HIF1A) and constitutively expressed HIF1 beta (HIF1B). Under normoxic conditions, HIF1A is bound to the tumor suppressor Von Hippel-Lindau (VHL) protein and degraded by the ubiquitin-proteasome pathway. However, hypoxia prevents the interaction between HIF1A and VHL, and thus, inhibits HIF1A degradation. As a result, HIF1A accumulates in the cytoplasm, and then translocates into the nucleus. HIF1A and HIF1B then dimerize, and bind to hypoxia response elements to stimulate the transcription of a large number of genes such as prostaglandin synthase, angiopoietin, protein tyrosine phosphatase, erythropoietin and VEGF (Wang et al., 1995; Semenza, 2007; Rey and Semenza, 2010) . Critchley et al. (2006) proposed that HIF1A is involved in the two signaling pathways implicated in menstruation: the alternate pathway (hypoxia-independent pathway) and the classical pathway (hypoxiadependent pathway). Hypoxia-dependent activation of HIF1A exists in almost all cells (Semenza, 2012) and experimental evidence demonstrates its existence in the hypoxia-independent pathway (Critchley et al., 2006) . In the human endometrium, HIF1A is abundant in the glandular and stromal cells of the functional layer during the late secretory and menstrual phases. HIF1A mRNA and protein levels dramatically increased on Days 1-3 of the cycle in rhesus macaque (Brenner and Slayden, 2012) , which suggests the importance of HIF1A in menstruation. Furthermore, a recent study found that HIF1A regulates VEGF expression under hypoxic conditions in human stromal cells in vitro (Critchley et al., 2006) . Hypoxia was also reported to increase VEGF expression via HIF1A in an endometrial epithelial cell line and in primary human endometrial stromal cells (Maybin et al., 2011a,b,c) . However, those studies were all performed in vitro. The regulatory mechanism in a whole organism is more complicated; therefore, understanding the mechanism by which HIF1 regulates VEGF in vivo is more desirable.
Menstruation, which exists only in primates, elephant shrews and some bat species, does not naturally occur in mice. The menstrual-like mouse model was first established in 1984 (Finn and Pope, 1984) . In this model, P4 withdrawal leads to endometrial breakdown after oil stimulation of stromal cell decidualization. The mouse model was later optimized in 2003 by Salamonson et al. (Brasted et al., 2003) , and in 2007, the pharmacological P4-withdrawal model was established by us . Recently, based on the mouse menstrual-like model, we obtained some interesting results regarding the mechanisms involved in menstruation (Li et al., 2012; Xu and He, 2012; Wang et al., 2013; Xu et al., 2013; Wu et al., 2014 ). An in vivo study using the mouse menstrual-like model protects the intact tissue structure including vascular, stromal and epithelial structures in the uterus, and provides a chance to observe the entire real-time dynamic process including endometrial breakdown and repair.
Here, we confirmed HIF1A mediated regulation of VEGF mRNA in both the mouse menstrual-like model and human decidual endometrial stromal cells. We determined that this regulation is initiated and it mainly occurs during endometrial breakdown, but not during its repair. Our investigation showed that the mRNA expression of both Vegf and Hif1a considerably increased during endometrial breakdown, when HIF1A activation and direct binding of HIF1A to the Vegf promoter also peaked. In addition, HIF1A inhibition in the mouse menstrual-like model confirmed HIF1A regulation of Vegf expression during endometrial breakdown, which was further confirmed in mouse and human decidual stromal cells.
Materials and Methods

Ethical approval
All human tissue collection followed a protocol for the protection of human subjects approved by the Ethical Committee of the National Research Institute for Family Planning and in accordance with the Declaration of Helsinki, together with informed consent from all patients.
VEGF regulation by HIF1A in a mouse menstrual-like model All animal studies were carried out in accordance with the principles and procedures of the Animal Ethical Committee of the National Research Institute of Family Planning.
Mice in vivo experiment
Establishment of mouse menstrual-like model
The mouse menstrual-like model was manipulated as described previously (Fan et al., 2008) . Briefly, mouse pseudopregnancy (in National Institutes of Health mice, 8 -10 weeks old, Beijing Tiantan Biological Products Co., Beijing, China) was achieved by mating virgin females with vasoligated males. The pseudopregnancy was confirmed by observation of vaginal plug (0 day of pregnancy). At 3.5 day, 20 ml of arachis oil was injected into the uterine lumen through dorsal incision to induce decidualization. At 5.5 day, 49 h after oil injection (referred to as 0 h in the text hereafter), mice were castrated by bilateral ovariectomized (OVX) to trigger P4 withdrawal. The mice were sacrificed at 0 h (n ¼ 9), 8 h (n ¼ 6), 12 h (n ¼ 8), 16 h (n ¼ 6), 24 h (n ¼ 7), 32 h (n ¼ 5), 40 h (n ¼ 5) and 48 h (n ¼ 5) after OVX (i.e. P4 withdrawal), respectively (Fig. 1) . The mice at 0 h, as a basic control, were sacrificed immediately at 49 h after artificial decidualization without ovariectomy. The mice in which vaginal bleeding did not occurred until 24 h were excluded from the experiments. Uteri were either fixed in 4% paraformaldehyde (prepared in phosphate buffered saline (PBS), pH 7.2) or frozen by liquid nitrogen and stored at 2808C for further investigation.
Successfully decidualized uteri uniformly enlarged at 49 h after oil injection. Decidualization was further confirmed by morphological observation performed by standard hematoxylin and eosin staining procedures. Uteri that had not sufficiently decidualized were omitted from the experiment. After P4 withdrawal, the endometrium underwent breakdown (necrosis and hemorrhage) and repair (angiogenesis and re-epithelialization), which mimicked the human menstruation. The endometrium remained intact at 8 h; from 12 to 16 h, stromal cells in a large areas exhibited necrosis and hemorrhage. The necrotic endometrium sloughed out at 24 h; then, the stromal cells were exposed in the uterine lumen, which quickly re-epithelialized at 32-40 h. Finally, the endometrium was restored at 48 h Fan et al., 2008) .
Immunohistochemistry
Mouse uteri were embedded in paraffin and dissected into 5-mm sections. Briefly, the cross-sections were deparaffinized, rehydrated and heated in citrate buffer (pH 6.0, 988C, 20 min) for antigen retrieval. Endogenous hydrogen peroxidase activity was quenched in 3% H 2 O 2 . The cross-sections were incubated with a mouse monoclonal primary antibody against VEGF (1:100, sc-7269; Santa Cruz, CA, USA), rabbit polyclonal antibody against HIF1A (1:100, NB100-479; Novus Biologicals, Littleton, CO, USA), at 378C for 1 h. Matched IgG2b was used as a negative control. Subsequently, the sections were incubated with horseradish peroxidase (HRP) conjugated secondary antibodies (Zymed Laboratories, Beijing, China) for 30 min. The immunoactive protein was visualized with 3,3-diaminobenzidine (DAB; ZLI-9031, Beijing Zhong Shan Golden Bridge Biological Technology Co. , Beijing, China). The sections were counterstained with hematoxylin and cover slips were then affixed with Permount TM mounting medium (Fisher Scientific, Waltham, MA, USA).
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was performed using SimpleChIP TM Enzymatic Chromatin IP Kit (9002, Cell Signaling Technology, Danvers, MA, USA). The reagents were mostly provided in the kit and the assay was performed in accordance with the manufacturer's instructions except a few modifications. Uterine tissues (100 mg/IP) were cut and washed with PBS (pH7.4) containing protein inhibitor cocktail (PIC) and phenylmethanesulfonyl fluoride. To this was added formaldehyde to a final concentration of 1.5% for protein-DNA cross-linking fixation. The reaction was stopped with glycine, followed by 100 g centrifugation at 48C for 5 min. Then the pellet was washed in PBS with PIC, the tissues were disaggregated into a single-cell suspension using electric homogenizer, then centrifuged at 1000 rpm for 5 min at 48C. After removing the supernatant, cell pellets were washed and resuspended in PBS with PIC. Then, 1 ml/immunoprecipitation (IP) of micrococcal nuclease was added for DNA digestion. To disrupt the nuclear membrane, the samples were disintegrated by ultrasonic cell crusher (Cole-Parmer Instruments, Vernon Hills, IL, USA) set at 40% input for each 10-s burst for seven times. The resulting DNA was purified and assessed by electrophoresis with a 1% agarose gel to ensure the DNA was digested to segments in a size of 150-900 bp. Each chromatin DNA preparation was then normalized to a final concentration of 200 mg/ml. To this was added 1 ml of normal rabbit IgG (negative control), 1 ml HIF1A (NB100-134, Novus) or 10 ml of histone H3 antibody (positive control), respectively. Primers used to detect the Vegf promoter were as follows: 5 ′ -AGAGAGATCAGGAGG AACAA-3 ′ and 5 ′ -TGCACTGTGTAGTCTGGCAGAGC-3 ′ (Kim et al., 2008) . Two micro liters of the purified DNA from each IP was used for real-time PCR analysis. Data obtained were expressed as Ct, which was the PCR cycle number at which the accumulated fluorescent signal in each reaction crosses the background threshold value. The result was analyzed using the percent of input method in the following equation: 2 (CT of the 2% Input Sample−CT of the IP Sample) × 2% = Percent total input (Li et al., 2012) .
Inhibition of HIF1A in mouse menstrual-like model
The HIF1A inhibitor 2-methoxyestradiol (2-ME) (LaVallee et al., 2002; Mabjeesh et al., 2003; Escuin et al., 2005; Machado-Linde et al., 2012; Hu et al., 2013 ) (Selleck, S1233) was dissolved in DMSO (2%, Sigma-Aldrich, St. Louis, MO, USA) and dilute with arachis oil. Mice (n ¼ 6) of menstrual-like model received 2-ME intraperitoneal injection by a final dosage of 100 mg/kg at 24, 4 and 12 h, respectively. Mice from the negative control group (n ¼ 5, vehicle group) were administrated with same DMSO and arachis oil solvent. Mice uteri from each group were collected at 24 h. The protein expression levels of VEGF and HIF1A were investigated by western blot assay. The expression level of Vegf mRNA was investigated by real-time PCR. The Figure 1 Mouse menstrual-like model. Arachis oil (20 ml) was injected into the uterine lumen at Day 3.5-post pseudocyesis to induce decidualization. Bilateral OVX was performed at Day 5.5 to trigger P4 withdrawal (0 h). The mouse uteri were collected at 12 h and within the subsequent 48 h at 8-h intervals.
endometrial breakdown evaluation was performed by relative breakdown area: breakdown area/decidualized area.
Endometrial stromal cell culture
Mouse decidual endometrial stromal cell culture and Hif1a knockdown
The mouse stromal cells from 10 artificially decidualized uteri were resuspended in basal medium: phenol red-free medium DMEM/F12 (Sigma-Aldrich), supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin, 10% charcoal-stripped fetal bovine serum (FBS; Thermo Scientific), 100 mM medroxyprogesterone acetate (MPA) and 10 nM 17 beta-estradiol (17b-E2) (Sigma-Aldrich). Cell cultures were maintained at 378C in humidified air with 5% CO 2 . Decidualized stromal cells were treated with either specific Hif1a siRNA duplexes or negative control duplex as described previously (Zhang et al., 2007) . The sequences of Hif1a siRNA duplexes were 5 ′ -AAGCAUUUCUCUCAUUUCCUCAUGG-3 ′ (sence) and 5 ′ -CCAUG AGGAAAUGAGAGAAAUGCUU-3 ′ (anti-sence). Transfection was performed using Lipofectamine TM 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Thereafter, the medium of decidual stromal cells was changed into steroid free medium (P4 withdrawal group) to mimic menstruation. The expression levels of Hif1a mRNA and protein were investigated to ensure knockdown effectiveness. Cells were harvested within 24 h after steroid withdrawal at 8-h intervals. The expression level of Vegf mRNA was investigated by real-time PCR.
Human endometrial stromal cell culture, decidualization and HIF1A knockdown Endometrial tissues for cell culture were obtained from uterine myoma patients (n ¼ 5) who underwent uteri hysterectomy surgery. The patients aged between 38 and 45 with regular menstrual cycles. Patients who had received hormone therapy were excluded from the experiment. Endometrial samples were histologically diagnosed as late proliferative phase or early secretory phase according to the criteria of Noyes et al. (1975) . The decidual stromal cells were prepared and cultured as described previously (Laird et al., 1997; Sugino et al., 2004) . Briefly, after culture for three passages, decidualization was induced by incubating cells in phenol red-free medium DMEM/ F12 containing 2% charcoal-stripped FBS (Hyclone, USA), 100 U/ml penicillin, 100 mg/ml streptomycin, 100 nM MPA and 10 nM 17b-E2 for 11 -14 days. Decidualization was confirmed by prolactin radioimmunoassay (Cangyuan Reide Biotechnology Co. Ltd, Beijing, China). Next, the decidualized stromal cells were treated with either specific HIF1A siRNA duplexes or negative control duplex as described previously (Sowter et al., 2003) . The sequences of HIF1A siRNA duplexes were, 5 ′ -CUGAUGACCA GCAA CUUGA dTdT-3 ′ (sense) and 5 ′ -UCAAGUUGCU GGUCAUCAG dTdT-3 ′ (anti-sense). Transfection and the following procedure were performed as described above. Cells were harvested within 36 h after steroid withdrawal at 12-h intervals.
Real-time PCR
Total RNA were extracted from the mouse uteri and human endometrial cells using TRIzol w Reagent (Invitrogen). The integrity and quality of RNA from all samples were detected by agarose gel electrophoresis and purities of RNA OD260/OD280 .1.8 were qualified for further experiments. cDNA was synthesized with 2 mg total RNA using reverse transcriptase with both Oligo-dT primers (25 pmol) and random primers (50 pmol) (Takara Bio, Otsu, Japan), in line with the manufacturer's protocols. The sequences of sense and anti-sense primers for real-time PCR are shown in Table I . Real-time PCR assay applied SYBR w Premix Ex Taq TM II real-time PCR kit (Takara Bio) and ABI StepOne TM real-Time PCR System (Applied Biosystems, Warrington, UK). PCR reaction conditions were 958C 3 min, 958C 10 s and 608C 30 s for a total of 40 cycles. b-actin served as the housekeeping control for calculating relative expression level using the comparative Ct (DDCt) method where the relative expression is calculated as 2 2DDCt (Livak and Schmittgen, 2001 ).
Western blot
The nuclear and cytoplasmic proteins of mouse uteri were extracted using a nuclear extraction kit (NE-PER, Pierce, USA) with PIC (Merck KGaA, Frankfurter Str., Darmstadt, Germany). A total of 15 mg of nuclear protein or cytoplasmic proteins from mouse uteri were resuspended in Laemmli buffer (125 mM Tris-HCl, pH 6.8, 4% sodium dodecyl sulfate, 5% 2-mercaptoethanol, 20% glycerol and 0.05% bromophenol blue) in a ratio 2:1(v/v) and denatured at 958C for 5 min. Proteins were separated in 4-12% Bis-Tris gels (Nu-PAGE Novex; Invitrogen) and transferred onto polyvinylidene difluoride membranes (Millipore, Watford, UK). Membranes were blocked in 5% skim milk in Tris Buf- 
Statistical analysis
The results are expressed as means + SD. Statistical significance of the quantitative data was determined using the Student's t-test. Data that did not conform to the normal distribution were analyzed using the rank sum test for significance. P , 0.05 was considered significant. 
Results
Up-regulation of Vegf expression in the mouse menstrual-like model
The VEGF protein was mainly expressed in decidual stromal cells at 0 h. The endometrium appeared extensively broken down at 16 and 24 h and the majority of the VEGF protein was present around the edges of the necrotic area. However, at 32 h, its expression was concentrated in reconstructed luminal epithelium cells and at 48 h, VEGF protein expression was reduced and primarily localized in epithelial cells ( Fig. 2A) . Time-dependent changes in the mRNA level of Vegf were observed. At 0 h, Vegf mRNA expression was relatively low. The levels gradually increased 8 h after P4 withdrawal, peaked at 12 h ( Fig. 2B ; P , 0.01), and then decreased until 32 h when Vegf mRNA levels were finally restored to the initial concentration. The mRNA levels of Vegf at 8, 12 and 16 h after P4 withdrawal were significantly higher than those at other time points ( Fig. 2B ; P , 0.01). At 12 h, the mRNA level of Vegf was almost 12 times higher than those at 0 h (Fig. 2B) .
Cytoplasmic VEGF protein expression was greater at the early stages after P4 withdrawal from 0 to 12 h, and then slightly decreased from 16 to 32 h when the endometrium was completely broken down ( Fig. 2C ; P , 0.01). At 40 and 48 h, VEGF protein expression was the lowest, while the endometrium was being repaired and essentially restored. These results show that Vegf mRNA expression was remarkably elevated by P4 withdrawal during the endometrial breakdown in the mouse menstrual-like model.
Up-regulation of Hif1a expression and its translocation into the nucleus in the mouse menstrual-like model
At 0 h, the immunoreactivity of the HIF1A protein was widely distributed in decidualized stromal cells and epithelial cells and was mainly localized in the cytoplasm. At 8 h, HIF1A nuclear staining was observed in intact stromal cells, then expanded at 12 h. At 16 h, HIF1A was observed at the junction of the necrosis area where the endometrium sloughs off from the basal zone and was predominantly located in nuclei. These results indicate that HIF1A was translocated from the cytoplasm into the nucleus. At 24 -48 h, HIF1A expression was reduced and very low immunostaining was observed around the ruptured surface of the broken down endometrium (Fig. 3A) .
Hif1a mRNA expression levels gradually increased at 8 h after P4 withdrawal, peaked at 12 h ( Fig. 3B ; P , 0.01), decreased thereafter and returned to the basal levels at 48 h. The expression levels at 8, 12, and 16 h were significantly higher than at other time points ( Fig. 3B ; P , 0.01). The highest expression of Hif1a was observed at 12 h and was about four times higher than at 0 h (Fig. 3B) . Notably, the time-dependent changes in mRNA expression of Vegf and Hif1a were similar, both demonstrated a peak expression at 12 h ( Figs 2B and 3B) .
To verify HIF1A activation, nuclear protein was extracted from mice uteri (Fig. 3C) . The expression of HIF1A proteins in the nucleus was relatively high at 0 h and then increased at 8, 12 and 16 h after P4 withdrawal (P , 0.01), which suggests that HIF1A protein was translocated into the nucleus during this period. At 24 h, HIF1A expression was remarkably reduced to levels even lower than those initially observed at 0 h (P , 0.01). Thereafter, HIF1A level slightly increased (P , 0.01) until 48 h, but its expression remained lower than was observed at the 16-h time point (P , 0.01). Taken together, nuclear HIF1A remained abundant during the endometrial breakdown and bleeding stages.
HIF1A directly bound onto the Vegf promoter during endometrial breakdown
The direct interaction of HIF1A with the Vegf promoter was investigated by the ChIP assay, by using the intact uterus of the mouse model. The amount of HIF1A bound Vegf promoter increased at 8 h, then peaked at 12 h, and was 2-fold higher than that observed at 0 h ( Fig. 4A ; P , 0.05). The HIF1A bound Vegf promoter significantly decreased at 16 h (P , 0.01), then decreased at the lowest level until 48 h (P , 0.01), to levels lower than observed at 0 h (Fig. 4A) . These changes correlate with the changes in mRNA expression of Vegf (Fig. 2B) and Hif1a (Fig. 3B) , as well as HIF1A nuclear translocation (Fig. 3A and C) . Thus, a regulative interaction occurred between HIF1A and the Vegf promoter after P4 withdrawal.
HIF1A inhibition suppressed VEGF expression and endometrial breakdown in the mouse menstrual-like model Two-ME was administered to mice in the menstrual-like model to inhibit HIF1A activation. The expression of HIF1A protein in the cytoplasm significantly increased in the 2-ME group, and was simultaneously decreased in the nucleus compared with the vehicle group ( Fig. 4B ; P , 0.01), indicating that HIF1A nuclear translocation was restricted by 2-ME mediated inhibition of HIF1A activation. The expression of Vegf mRNA and protein was significantly suppressed by 2-ME at 24 h, compared with that observed in the vehicle group ( Fig. 4C ; P , 0.01). Endometrial breakdown was also suppressed in the uterus, since the uterus of the vehicle group appeared dark red but remained pink in the 2-ME group (Fig. 4D) . Histomorphological analyses revealed that the endometrium in the vehicle group was mostly broken down at 24 h, whereas only partial breakdown was observed in the 2-ME group and a substantial part of the decidual endometrium was still intact in this group. An evaluation of endometrial breakdown demonstrated that the breakdown area of the 2-ME group was significantly smaller than that of the vehicle group ( Fig. 4D; P , 0.01) . These results show that the mRNA and protein Up-regulation of VEGF expression after P4 withdrawal in mouse and human decidual stromal cells and its suppression by HIF1A knockdown
The regulation of HIF1A and VEGF was further investigated using mouse and human decidual stromal cells. HIF1A regulation of VEGF mRNA expression was investigated by HIF1A knockdown, and knockdown efficiency was confirmed by quantification of HIF1A mRNA and protein ( Fig. 5A and C ; P , 0.01). In mouse cells, the expression of Vegf mRNA was relatively low at 0 and 8 h. However, by 16 and 24 h, Vegf mRNA levels gradually increased to levels that were 2.5 times higher than observed at 0 h ( Fig. 5B ; P , 0.05, P , 0.01). Vegf expression was significantly suppressed by Hif1a knockdown and remained even lower than that observed at 0 h (Fig. 5B) . Similar results were also obtained in human decidual stromal cells. After decidualization, the relative expression of both HIF1A and VEGF mRNA remained relatively low and no significant changes were detected within 6 days (data not shown). After hormone deprivation, VEGF mRNA levels significantly increased from 24 to 36 h, and were up to 25 times higher than at 0 h ( Fig. 5D ; P , 0.01). VEGF mRNA expression was suppressed by HIF1A Figure 4 Interaction between HIF1A and the Vegf promoter, and the effect of 2-ME on the expression of HIF1A and VEGF and on uteri morphology in the mouse menstrual-like model. (A) The ChIP assay was conducted to study the interaction between HIF1A and the Vegf promoter. The results showed the amount (percent of input) of Vegf promoter bound by HIF1A protein at each time point (gray column). The negative control (Mock IgG) represents the IP background (dark column). Data are represented as mean + SD and are representative of the percent of input of the Vegf promoter at each time point (n ¼ 3). (B) HIF1A expression in the cytoplasm and nucleus after 2-ME administration was investigated by western blot. Two-ME significantly increased HIF1A expression in the cytoplasm and reduced its expression in the nucleus at 24 h after treatment. (C) Vegf mRNA and protein expression after 2-ME administration. Two-ME significantly suppressed the mRNA and protein expressions of Vegf. (D) Macroscopic and histomorphometric observation of mouse uteri at 24 h. Two-ME administration significantly suppressed endometrial breakdown. The magnified fields are, respectively, indicated by the black square, bar 400 and 50 mm. The relative area of endometrium breakdown was defined as the breakdown area (black line)/the decidualized area (red line). **P , 0.01. knockdown about 0.4-fold compared with the control group ( Fig. 5D ; P , 0.01).
Discussion
In this study, we utilized the mouse menstrual-like model, and mouse and human decidual endometrial stromal cells to study the regulatory mechanism of VEGF in the endometrium during menstruation in vivo and in vitro. We discovered that the onset and peak time that specific interaction between HIF1A and the Vegf promoter occurred was during endometrial breakdown. HIF1A inhibition by an HIF1A inhibitor and Hif1a silencing further confirmed the regulation in vivo and in vitro.
In the mouse menstrual-like model, Vegf mRNA expression in the endometrium was up-regulated by P4 withdrawal in our study. Similarly, in rhesus macaque, VEGF mRNA was also up-regulated in the glands and stroma of the superficial endometrial zones after P4 withdrawal (Nayak and Brenner, 2002) . Furthermore, studies employing VEGF receptor (VEGFR) blockade in the macaque model indicate that VEGF is required for angiogenesis in the endometrium, especially re-epithelialization after endometrial breakdown (Nayak and Brenner, 2002; Fan et al., 2008) . These findings demonstrate that VEGF plays an important role in endometrial repair.
Previous study investigating the effect of VEGFR blockade in the mouse menstrual-like model confirm that VEGF functions during endometrial repair (Fan et al., 2008) ; however, the expression of HIF1A or VEGF and their regulation were not fully clarified. Interestingly, although VEGF was reported to function primarily during endometrial repair, in our study, we found Hif1a mRNA and protein expression dramatically VEGF mRNA expression (dark column) was significantly increased by steroid withdrawal, while HIF1A knockdown significantly suppressed the increase compared with those in the negative control (gray column). *P , 0.05, **P , 0.01. VEGF regulation by HIF1A in a mouse menstrual-like model increased during endometrial breakdown. Moreover, nuclear expression of HIF1A was highly elevated from 8 to 16 h after P4 withdrawal. This was similarly observed in human endometrium, that HIF1A mRNA increased and was activated during the secretory and menstrual phase (Critchley et al., 2006) , indicating that HIF1A was activated during endometrial breakdown. The same expression pattern was also observed in Vegf mRNA, and HIF1A and VEGF protein co-localization occurred from 12 to 24 h after P4 withdrawal. The expression and activation of HIF1A was concurrent with Vegf mRNA expression, which started to increase and peaked during endometrial breakdown. Furthermore, the relative amount of HIF1A bound to the Vegf promoter also gradually increased during endometrial breakdown and peaked at 12 h, which was concurrent with the highest expression of Vegf mRNA. These results further demonstrate that direct regulation of Vegf by HIF1A is initiated during endometrial breakdown. To confirm this finding further, the HIF1A inhibitor 2-ME was administered to mice during endometrial breakdown, thereby suppressing HIF1A nuclear translocation. Both the mRNA and protein expressions of VEGF were significantly suppressed by HIF1A inhibition at 24 h, during the greatest extent of endometrial breakdown. These results show that the direct regulation of HIF1A to Vegf mRNA started and peaked during endometrial breakdown.
There was a clear distinction in the intervals for VEGF function and mRNA regulation. This could possibly be due to the involvement of the VEGFR in the functional regulation of VEGF, since VEGF functions by binding to the VEGFR. In humans, VEGFR2, which regulates proliferation, is reported strongly expressed in endothelial cells during the proliferative phase (Smith, 2001) . We also previously reported that the expression of Vegfr2 mRNA peaked at 40 h during endometrial repair in mouse menstrual-like model , which demonstrates consistency in VEGF's role in endometrial repair. Moreover, a time difference between the expression of Vegf and Vegfr2 mRNA was also found during early pregnancy in mice. The protein and mRNA expression of Vegf was increased since Day 1, whereas Vegfr2 expression did not increase until Day 3 in mice (Walter et al., 2010) . Therefore, we propose that the regulation of Vegf mRNA during endometrial breakdown may serve as a preparation and early storage for later endometrial repair. However, the reason for the extended preparation time required for HIF1A regulation of VEGF mRNA is complicated and therefore requires further exploration.
The limitations inherent in sampling the human endometrium and the difficulty in collecting endometrial tissues at the exact time after P4 withdrawal significantly influence the feasibility of an accurate study. This is evident in the contradictory results obtained with previous studies investigating whether nuclear HIF1A is expressed in the endometrium; these contradictory results were attributed to the limitation of tissue collection (Zhang and Salamonsen, 2002; Critchley et al., 2006) . In contrast, with the mouse menstrual-like model, we are able to investigate the uterine changes at regular and freely selectable time intervals, while preserving tissue integrity. Thus, the mouse menstrual-like model avoids the inherent drawbacks of human endometrium sampling and allows for observation within a given time course, while maintaining tissue integrity (Li et al., 2012) .
HIF1, as a nuclear transcription factor, is an upstream inducer of critical angiogenic growth factors (Rey and Semenza, 2010) . Recent studies in menstruation suggested that HIF1A was involved in the expression of interleukin 8 (Maybin et al., 2011a,b,c) , adrenomedullin (Maybin et al., 2011a,b,c) , stromal cell-derived factor-1 and VEGF (Fan et al., 2008; Maybin et al., 2011a,b,c; Tsuzuki et al., 2012) . However, we discovered that the greatest expression and activation of HIF1A occurred at 12 h. Moreover, early stage inhibition of HIF1A significantly suppressed endometrial breakdown. These results indicate that genes downstream of HIF1A regulation are important for endometrial breakdown, which indicates that HIF1A is a key regulator of endometrial breakdown.
The HIF1A inhibitor 2-ME was found to affect the immune system by targeting T lymphocytes and NK cells in a dose-and tissue-dependent manner (Duncan et al., 2012; Stubelius et al., 2014) . Menstruation is regarded as an inflammatory process, since it involves an influx of considerable numbers of inflammatory cells into the uterus, including leukocytes, uterine NK cells, neutrophils, monocytes and macrophages (Evans and Salamonsen, 2012) . Moreover, macrophages are an important source of VEGF (Riazy et al., 2009; Wu et al., 2010; Obeid et al., 2013) . Therefore, HIF1A regulation of VEGF, which was particularly demonstrated by HIF1A inhibition with 2-ME administration, may be mediated by macrophages. This mechanism was not investigated here; however, it certainly deserves further exploration.
Another notable phenomenon was that HIF1A protein nuclear translocation occurred at 0 h, before P4 withdrawal, in endometrial luminal epithelial and the surrounding stromal cells. A similar phenomenon was also found in mice during early pregnancy at Day 5 (Daikoku et al., 2003) . Hypoxia was shown to be a key factor in the process of placental development (Genbacev et al., 1997; Patel et al., 2010; Semenza, 2012) . Here, HIF1A was activated without embryo stimulus in artificially induced decidual endometrium, indicating that hypoxic conditions and HIF1A activation during pregnancy are likely an active processes of the decidual endometrium.
In this study, the regulation of VEGF mRNA by HIF1A was explored in the decidual stromal cells. In previous studies, the regulation of VEGF by HIF1A was explored in human non-decidual endometrial cells or cell lines (Yoshie et al., 2009; Maybin et al., 2011a,b,c; Tsuzuki et al., 2012) . However, it has been clarified that decidualization is indispensable for menstruation (Finn and Pope, 1984; Brasted et al., 2003; Emera et al., 2012) . To the best of our knowledge, this is the first study that confirms the regulation of VEGF by HIF1A in decidual stromal cells, thus improving the understanding of the physiology of menstruation.
In summary, this study provided in vivo evidence for the direct regulation of Vegf mRNA expression by HIF1A in menstruation and demonstrates that this regulation begins and peaks during endometrial breakdown, not repair. Endometrial cyclic breakdown and repair is a characteristic that distinguishes advanced primates from lower animals, and serves as a better mechanism for pregnancy preparation. VEGF plays a key role in endometrial repair, which is also crucial in the preparation for a successful pregnancy. In our study, the time differences discovered between HIF1A-Vegf mRNA regulation and VEGF function provides a deeper understanding of the inseparable relationship between the processes of endometrial breakdown and repair. The findings also provide new insight, and a theoretical basis for the treatment of pregnancy failure.
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